1. | mrwhtwabbit | |
2. | emielnl | |
3. | codcoleu1ou0m4sl | |
4. | ree222 | |
5. | dimespent |
1. | mrwhtwabbit | |
2. | emielnl | |
3. | codcoleu1ou0m4sl | |
4. | ree222 | |
5. | dimespent |
1. | emielnl 03/07/2018 Reports new clinical data demonstrate high vaccine efficacy of Fluarix Tetra in children 6-35 months of age |
2. | dimespent 04/03/2018 US FDA accepts Biologics license application for moxetumomab pasudotox in hairy cell leukemia |
3. | ree222 03/09/2018 Announces positive EU Approval for labelling update to Relvar Ellipta in patients with Asthma |
4. | mrwhtwabbit 02/07/2018 Going for the throat |
5. | codcoleu1ou0m4sl 01/25/2018 Johnson & Johnson has pulled out of the race to buy Pfizer's consumer health business, leaving GlaxoSmithKli… |
6. | mrwhtwabbit 07/25/2018 Reports negative outcome of the FDA Advisory Committee on mepolizumab for the treatment of COPD patients on m… |
7. | mrwhtwabbit 02/15/2018 Receives European approval for expanded indication for Fluarix Tetra (Influenza Vaccine) for ages six months … |
8. | emielnl 02/07/2018 GlaxoSmithKlines Bexsero receives Breakthrough Therapy Designation from FDA |
9. | mrwhtwabbit 02/07/2018 Good beat. |
10. | emielnl 03/23/2018 Shingrix approved in Europe and Japan for the prevention of shingles in adults aged 50 and over |